Cancer Cell Q1 Unclaimed

Cell Press United States
Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Cancer Cell is a journal indexed in SJR in Cell Biology and Oncology with an H index of 398. It is an CC BY-NC-ND Journal with a Single blind Peer Review review system, and It has a price of 4704 €. The scope of the journal is focused on Cancer, Cancer Cell, Cancer Biology. It has an SJR impact factor of 17,507 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 17,507.

Cancer Cell focuses its scope in these topics and keywords: cancer, cell, breast, myeloid, signaling, therapeutic, reprogramming, transformation, translation, ductal, ...

Type: Journal

Type of Copyright: CC BY-NC-ND

Languages: English

Open Access Policy: Open Choice

Type of publications:

Publication frecuency: -


4704 €

Inmediate OA


Embargoed OA

0 €

Non OA


Cancer Cell


SJR Impact factor


H Index


Total Docs (Last Year)


Total Docs (3 years)


Total Refs


Total Cites (3 years)


Citable Docs (3 years)


Cites/Doc (2 years)




No comments ... Be the first to comment!

Aims and Scope

cancer, cell, breast, myeloid, signaling, therapeutic, reprogramming, transformation, translation, ductal, target, pancreatic, protein, promotes, epigenetic, progression, molecular, shock, cancerpdependent, arrest, axis, bladder, Cancer, Cancer Cell, Cancer Biology

Best articles by citations

Tissue States Provide Novel Insights into Attributes that Drive Metastasis

View more

Targeting oncogene dependence and resistance

View more

New Antibody to Stop Tumor Angiogenesis and Lymphatic Spread by Blocking Receptor Partnering

View more

Glycans Pave the Way for Immunotherapy in Triple-Negative Breast Cancer

View more

Homeobox genes and cancer

View more

Tumor-mediated apoptosis of cancer-specific T lymphocytes - Reversing the "kiss of death"?

View more

ChIP-ping Away at EWS/ETS Transcription Networks

View more

Greeting from the new Editor

View more

HNPCC mutations in hMSH2 result in reduced hMSH2-hMSH6 molecular switch functions

View more

Focus on kidney cancer

View more

In vivo imaging of molecular-genetic targets for cancer therapy

View more

Credibility and Reproducibility

View more

Wiring the angiogenic switch: Ras, Myc, and Thrombospondin-1

View more

Focus on prostate cancer

View more

Cdk2 dethroned as master of S phase entry

View more

Cancer Metabolism: Is Glutamine Sweeter than Glucose?

View more

An exciting forum for cancer research

View more

Antagonism of Myc functions by Arf

View more

SnapShot: Chronic Lymphocytic Leukemia

View more

Response to Chauhan et al.: Interstitial Pressure and Vascular Collapse in Pancreas Cancer - Fluids and Solids, Measurement and Meaning

View more

Cancer Molecular Analysis Project: Weaving a rich cancer research tapestry

View more


View more

Take care of your chromosomes lest cancer take care of you

View more